Waverley Pharma Inc (WAVE) Stock Price & News

All values in CAD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	275,66 миң	297,00 миң	287,13 миң	314,47 миң
Cost of goods sold	206,97 миң	178,23 миң	193,54 миң	202,42 миң
Cost of revenue	206,97 миң	178,23 миң	193,54 миң	202,42 миң
Research and development expenses	12,00 миң	350,00	-	1,09 миң
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	245,00 миң	270,08 миң	216,44 миң	208,81 миң
Operating expense	256,99 миң	270,43 миң	216,44 миң	209,90 миң
Total operating expenses	463,96 миң	448,66 миң	409,98 миң	412,33 миң
Operating income	-188,30 миң	-151,66 миң	-122,85 миң	-97,86 миң
Other non operating income	-441,00	69,00	-30,00	-53,00
EBT including unusual items	-236,36 миң	-197,31 миң	-165,47 миң	-143,67 миң
EBT excluding unusual items	-236,36 миң	-197,31 миң	-165,47 миң	-143,67 миң
Income tax expense	1,63 миң	-	-	-
Effective tax rate	-0,69%	-	-	-
Other operating expenses	-	-	-	-
Net income	-237,99 миң	-197,31 миң	-165,47 миң	-143,67 миң
Net profit margin	-86,33%	-66,43%	-57,63%	-45,69%
Earnings per share	-	-	-	-
Interest and investment income	-	24,00	2,36 миң	-
Interest expense	-47,72 миң	-45,90 миң	-44,72 миң	-46,44 миң
Net interest expenses	-47,72 миң	-45,88 миң	-42,37 миң	-46,44 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	-167,78 миң	-137,19 миң	-102,41 миң	-77,24 миң
Gain or loss from assets sale	-	-	-	-

Finance